US Patent Issued to Orionis Biosciences, VIB VZW, UNIVERSITEIT Gent on Oct. 6 for "Methods of cancer treatment with PD-L1 targeted interferon therapeutic agents" (Belgian, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,233, issued on Oct. 6, was assigned to Orionis Biosciences BV (Ghent, Belgium), VIB VZW (Ghent, Belgium) and UNIVERSITEIT Gent (Ghent, Belgium).

"Methods of cancer treatment with PD-L1 targeted interferon therapeutic agents" was invented by Jan Tavernier (Balegem, Belgium) and Nikolai Kley (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to chimeric proteins that find use in various immunotherapies. Particularly, the present invention provides targeted therapeutic agents that modulate the immune system for the treatment of diseases such as cancer."

The patent was filed on April 18, 2023, under App...